NBC News: Rare Mutation Points to Possible New Antiviral Drugs; polyDNA Recommends Gene-Eden-VIR, a Successful, Natural Antiviral Remedy

A treatment against most viruses is being developed based on a rare mutation discovered in a brother and sister, according to an NBC News report published on April 10, 2014 (1). polyDNA reviews the report and recommends Gene-Eden-VIR, a natural antiviral that was successfully tested in a post-marketing clinical study that followed FDA guidelines.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
Since there is no treatment on the market that makes one immune to most viruses, we recommend Gene-Eden-VIR. This natural antiviral was designed to help the immune system target latent viruses. - Mike Evans, polyDNA

Rochester, NY (PRWEB) April 17, 2014

polyDNA has learned that “A brother and sister with an extremely rare genetic condition have a stunning ability to fight off viruses - an ability that could lead to a new family of antiviral drugs (1).” Researchers reported in the New England Journal of Medicine that the children’s bodies stop viruses from building a protective shell, “which leaves viruses ‘naked’ and vulnerable (1).” Tests show that the children’s bodies “resist herpes, dengue and hepatitis C viruses (1).” Researchers believe that they will be able to use lessons learned from these children “to learn how to modulate the immune system” and create therapies against most viruses for the general population. However, it may take many years before these therapies enter the market. polyDNA therefore recommends Gene-Eden-VIR, a natural antiviral that was proven to reduce symptoms of herpes and hepatitis C infections in a post-marketing clinical study that followed FDA guidelines.

While the mutation that allows the children to resist viral infections may allow researchers to eventually develop therapies against most viruses, the same mutation causes severe disabilities in the children, including seizures, developmental delays, fragile bones and hearing loss (1). Dr. Sergio Rosenzweig said that the mutation “affects almost every organ, every function of the body (1).” It also “prevents the children’s bodies from finishing a very basic biological function called glycosylation, which is the process of attaching sugars to proteins (1).” Viruses cannot attack the children because many of them “use their victim’s glycosylation to build a protective shield (1).”

Dr. Rosenzweig believes that it is possible to block glycosylation temporarily, “not long enough to damage a person’s cells, but long enough to make a virus naked (1).” Unfortunately, there is no treatment currently available that can make a virus ‘naked’ and unable to form a protective shield.

“Since there is no treatment on the market that makes one immune to most viruses, we recommend Gene-Eden-VIR. This natural antiviral was designed to help the immune system target latent viruses. It was shown to reduce the symptoms of many viral infections in a recent post-marketing study that followed FDA guidelines.” - Mike Evans, polyDNA

A study published on August 12, 2013 in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs, showed that Gene-Eden-VIR reduced viral symptoms. Study authors wrote that, “Individuals … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR (2).” The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms (2).”

Research shows that an infection with many viruses also causes a feeling of physical and mental fatigue. Since Gene-Eden-VIR is antiviral, a second post-marketing clinical study showed that Gene-Eden-VIR decreases the feeling of physical and mental fatigue. That study was published in March, 2014 in the journal Pharmacology & Pharmacy (3).

To read the study on the antiviral nature of Gene-Eden-VIR, visit http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.UzPvtaiSz90.

To read the study on Gene-Eden-VIR’s effects on reducing physical and mental fatigue, visit http://www.scirp.org/journal/PaperInformation.aspx?PaperID=44234#.UzPwAqiSz90.

To learn more about Gene-Eden-VIR, visit http://www.gene-eden-vir.com. All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) Kids With Rare Disease May Hold Secret to Stopping Viruses. Published on April 10, 2014.
http://www.nbcnews.com/health/health-news/kids-rare-disease-may-hold-secret-stopping-viruses-n76251

(2) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.UzPyRKiSz90

(3) Gene-Eden-VIR Decreased Physical and Mental Fatigue in a Post Marketing Clinical Study That Followed FDA Guidelines; Results Support Microcompetition Theory. Published in March, 2014.
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=44234#.UzPymKiSz90

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.